THERANOSTICS 2016* , ,
Presentations this author is a contributor to:
177Lu-PSMA radioligand therapy of prostate cancer in patients with single functioning kidney (#85)
8:30 AM
Aviral Singh
Conference Breakfast: Moderated Poster Walk - Prostate tumours
Efficacy of peptide receptor radionuclide therapy in neuroendocrine neoplasms: the Bad Berka experience in 1048 patients over more than a decade (#64)
8:30 AM
Harshad R Kulkarni
Conference Breakfast: Moderated Poster Walk - Neuroendocrine tumours
Prostate specific membrane antigen targeted radioligand therapy of metastatic castration-resistant prostate cancer using Lu-177 PSMA-617: safety, efficacy and dosimetry in comparison with Lu-177 PSMA I&T (#33)
4:06 PM
Harshad R Kulkarni
Improving Patient Outcomes with PSMA Theranostics